The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes
Open accessAbstract
Nanostructured Lipid Carriers (NLC) are nano-sized colloidal drug delivery system that contains a lipid mixture consisting of both solid and liquid lipids in their core. This Lipid-Based Nanosystem is introduced as a biocompatible, non-toxic, and safe nano-drug delivery system as compared to polymeric or metallic nanoparticles. Due to its safety, stability, and high drug loading capacity compared to other lipid-based nanocarriers, NLC gained the attention of researchers to formulate safe and effective drug carriers. The ability to increase drug solubility and permeability while encapsulating the drug in a lipidic shell makes them an ideal carrier for drug delivery through difficult-to-achieve routes. Surface modification of NLC and the use of various additives result in drug targeting and increased residence time. With such qualities, NLCs can be used to treat a variety of diseases such as cancer, infections, neurodegenerative diseases, hypertension, diabetes, and pain management. This review focuses on the recent developments being made to deliver the drugs and genes through different routes via these nanocarriers. Here, we also discuss about historical background, structure, types of NLC and commonly employed techniques for manufacturing lipid-based nanocarriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Fahmy, U. A., Ahmed, O. A. A., Badr-Eldin, S. M., Aldawsari, H. M., Okbazghi, S. Z., Awan, Z. A., Bakhrebah, M. A., Alomary, M. N., Abdulaal, W. H., Medina, C., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s258791 · Cited by 47
RetractedYu, G., Ali, Z., Khan, A. S., Ullah, K., Jamshaid, H., Zeb, A., Imran, M., Sarwar, S., Choi, H., & Din, F. U. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s299443 · Cited by 47
RetractedDiffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“More than 50 years ago A D Bangham discovered “swollen phospholipids” as a model of the cell membrane, which was later termed Liposome.(3) From there on the spontaneous rearrangement of lipids to form nano colloidal particles have been constantly explored and evolved.”
International Journal of Nanomedicine
(2020) · International Journal of Nanomedicine · doi:10.2147/ijn · Cited by 2,747
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.007 · Cited by 1,014
Mohammadi-Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 970
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Al-Dosari, M. S., & Gao, X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9143-y · Cited by 706
Nanostructured lipid carriers (NLC) in cosmetic dermal products☆
MULLER, R., PETERSEN, R., HOMMOSS, A., & PARDEIKE, J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.012 · Cited by 700
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
H. Muller, R., Shegokar, R., & M. Keck, C. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799062 · Cited by 544
Thi, T. T. H., Suys, E. J. A., Lee, J. S., Nguyen, D. H., Park, K. D., & Truong, N. P. (2021) · Vaccines · doi:10.3390/vaccines9040359 · Cited by 525
Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery
Chauhan, I., Yasir, M., Verma, M., & Singh, A. P. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.021 · Cited by 518
Oral lipid-based drug delivery systems – an overview
Kalepu, S., Manthina, M., & Padavala, V. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.10.001 · Cited by 494
Recent advances in the development of gene delivery systems.
Sung, Y., & Kim, S. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0156-z · Cited by 458
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
Haider, M., Abdin, S. M., Kamal, L., & Orive, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030288 · Cited by 451
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Elmowafy, M., & Al-Sanea, M. M. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.07.015 · Cited by 382
Nanostructured lipid carriers and their current application in targeted drug delivery
Jaiswal, P., Gidwani, B., & Vyas, A. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.909822 · Cited by 372
Recent Advances in Nanomaterials for Gene Delivery—A Review
Riley, M., & Vermerris, W. (2017) · Nanomaterials · doi:10.3390/nano7050094 · Cited by 354
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Duong, V.-A., Nguyen, T.-T.-L., & Maeng, H.-J. (2020) · Molecules · doi:10.3390/molecules25204781 · Cited by 338
Lipid-based nano-delivery systems for skin delivery of drugs and bioactives
Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00219 · Cited by 304
Costa, C. P., Moreira, J. N., Sousa Lobo, J. M., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 303
Jain, S., Patel, N., Shah, M. K., Khatri, P., & Vora, N. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.10.001 · Cited by 283
A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs
Li, Q., Cai, T., Huang, Y., Xia, X., Cole, S., & Cai, Y. (2017) · Nanomaterials · doi:10.3390/nano7060122 · Cited by 282
Nanotoxicity: A Key Obstacle to Clinical Translation of siRNA-Based Nanomedicine
Xue, H. Y., Liu, S., & Wong, H. L. (2014) · Nanomedicine · doi:10.2217/nnm.13.204 · Cited by 250
Current approaches in lipid-based nanocarriers for oral drug delivery
Plaza-Oliver, M., Santander-Ortega, M. J., & Lozano, M. V. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00908-7 · Cited by 249
Solid lipid nanoparticles for ocular drug delivery
Seyfoddin, A., Shaw, J., & Al-Kassas, R. (2010) · Drug Delivery · doi:10.3109/10717544.2010.483257 · Cited by 247
The challenges of oral drug delivery via nanocarriers
Reinholz, J., Landfester, K., & Mailänder, V. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1501119 · Cited by 233
Narang, J., Khan, S., Baboota, S., Ali, J., Khan, S., & Narang, R. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.167661 · Cited by 202
Self-citationStrategies to prolong the residence time of drug delivery systems on ocular surface
Grassiri, B., Zambito, Y., & Bernkop-Schnürch, A. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2020.102342 · Cited by 199
Solid Lipid Nanoparticles as Carriers of Natural Phenolic Compounds
Borges, A., de Freitas, V., Mateus, N., Fernandes, I., & Oliveira, J. (2020) · Antioxidants · doi:10.3390/antiox9100998 · Cited by 185
Yang, H. N., Chu, X., Cui, L., Fu, S., Gao, C., Li, Y., & Sun, B. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1745328 · Cited by 169
Erasmus, J. H., Khandhar, A. P., Guderian, J., Granger, B., Archer, J., Archer, M., Gage, E., Fuerte-Stone, J., Larson, E., Lin, S., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.010 · Cited by 161
Shao, Z., Shao, J., Tan, B., Guan, S., Liu, Z., Zhao, Z., He, F., & Zhao, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77837 · Cited by 148
Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye
Vaneev, A. N., Tikhomirova, V. E., Chesnokova, N. B., Popova, E. V., Валерьевна, Б. О., Kost, O. A., & Klyachko, N. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212368 · Cited by 144
Qamar, Z., Qizilbash, F. F., Iqubal, M. K., Ali, A., Narang, J. K., Ali, J., & Baboota, S. (2019) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/1872211314666191224115211 · Cited by 141
Garbuzenko, O. B., Kuzmov, A., Taratula, O., Pine, S. R., & Minko, T. (2019) · Theranostics · doi:10.7150/thno.39816 · Cited by 132
Nanostructured Lipid Carriers (NLC): The Second Generation of Solid Lipid Nanoparticles
Müller, R. H., Alexiev, U., Sinambela, P., & Keck, C. M. (2016) · Springer eBooks · doi:10.1007/978-3-662-47862-2_11 · Cited by 130
Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
Shamma, R. N., & Aburahma, M. H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s73010 · Cited by 127
Rajinikanth, P. S., & Chellian, J. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s117511 · Cited by 122
Challenges and Future Prospects of Nanoemulsion as a Drug Delivery System
Yukuyama, M. N., Kato, E. T. M., Löbenberg, R., & Bou‐Chacra, N. A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161027111957 · Cited by 120
Nordin, U. U. M., Ahmad, N., Salim, N., & Yusof, N. S. M. (2021) · RSC Advances · doi:10.1039/d1ra06087b · Cited by 119
Youssef, A. A. A., Dudhipala, N. R., & Majumdar, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060572 · Cited by 118
Nanomedicines: The magic bullets reaching their target?
Flühmann, B., Ntai, I., Borchard, G., Simoens, S., & Mühlebach, S. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.11.019 · Cited by 116
Soni, K., Rizwanullah, M., & Kohli, K. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1408124 · Cited by 114
Liang, J. F., Liu, Y., Liu, J., Li, Z., Fan, Q., Jiang, Z., Yan, F., Wang, Z., Huang, P., & Feng, N. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0391-9 · Cited by 102
Yin, J., Hou, Y., Yin, Y., & Song, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s144615 · Cited by 96
Viegas, J. S. R., Praça, F. S. G., Caron, A. L., Suzuki, I., Silvestrini, A. V. P., Medina, W. S. G., Ciampo, J. O. D., Kravicz, M., & Bentley, M. V. L. B. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00723-6 · Cited by 93
Agrawal, Y. O., Mahajan, U. B., Mahajan, H. S., & Ojha, S. K. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s247007 · Cited by 91
Jnaidi, R., Almeida, A. J., & Gonçalves, L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090860 · Cited by 89
Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery
Bhattacharjee, A., Das, P. J., Adhikari, P., Marbaniang, D., Pal, P., Ray, S., & Mazumder, B. (2018) · European Journal of Ophthalmology · doi:10.1177/1120672118769776 · Cited by 85
Yu, Y., Feng, R., Li, J., Wang, Y., Song, Y., Tan, G., Liu, D., Liu, W., Yang, X., Pan, H., et al. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2018.08.002 · Cited by 83
Nasal Drug Delivery Systems: An Overview
Ghori, M. U., Mahdi, M. H., Smith, A. M., & Conway, B. R. (2015) · University of Huddersfield Repository (University of Huddersfield) · doi:10.12691/ajps-3-5-2 · Cited by 82
Salem, L. H., El-Feky, G. S., Fahmy, R. H., El-Gazayerly, O. N., & Abdelbary, A. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.04.007 · Cited by 82
Khan, A. A., Mudassir, J., Akhtar, S., Murugaiyah, V., & Darwis, Y. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020097 · Cited by 81
Garbuzenko, O. B., Ivanova, V., Kholodovych, V., Reimer, D. C., Reuhl, K. R., Yurkow, E. J., Adler, D., & Minko, T. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.04.005 · Cited by 74
Kar, N., Chakraborty, S., De, A. K., Ghosh, S., & Bera, T. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.046 · Cited by 72
Tan, S. L. J., & Billa, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111817 · Cited by 72
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
Wang, H., Liu, S., Li, J., Chu, F., Zhou, Y., He, Z., Guo, M., Chen, C., & Xu, L. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0596-x · Cited by 64
Giardiello, M., Liptrott, N. J., McDonald, T. O., Moss, D., Siccardi, M., Martin, P., Smith, D., Gurjar, R., Rannard, S. P., & Owen, A. (2016) · Nature Communications · doi:10.1038/ncomms13184 · Cited by 63
Deshkar, S. S., Jadhav, M. S., & Shirolkar, S. V. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2021.016 · Cited by 61
Savić, V., Milić, J., Nikolić, I., Marković, B. D., Čalija, B. R., Cekic, N. D., & Savic, S. D. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118624 · Cited by 56
Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation
González‐Fernández, F. M., Bianchera, A., Gasco, P., Nicoli, S., & Pescina, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040447 · Cited by 55
Yang, G., Wu, F., Chen, M., Jin, J., Wang, R., & Yuan, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s194934 · Cited by 52
Nanophyto-gel against multi-drug resistant Pseudomonas aeruginosa burn wound infection
Wen, M. M., Abdelwahab, I. A., Aly, R. G. M., & El‐Zahaby, S. A. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1889720 · Cited by 50
Chen, Z., Lai, X., Song, S., Zhu, X., & Zhu, J. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1038857 · Cited by 49
Collagen scaffold-mediated delivery of NLC/siRNA as wound healing materials
Tezgel, Ö., Distasio, N., Masci, V. L., Taddei, A., Szarpak, A., Auzély‐Velty, R., Navarro, F. P., & Texier, I. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101421 · Cited by 49
Puglia, C., Santonocito, D., Ostacolo, C., Sommella, E., Campiglia, P., Carbone, C., Drago, F., Pignatello, R., & Bucolo, C. (2020) · Nanomaterials · doi:10.3390/nano10020287 · Cited by 48
El‐Halim, S. M. A., Abdelbary, G. A., Amin, M. M., Zakaria, M. Y., Shamsel‐Din, H. A., & Ibrahim, A. B. (2020) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-020-00355-8 · Cited by 47
Karn-orachai, K., Smith, S. M., Phunpee, S., et al. (2014) · Journal of Microencapsulation · doi:10.3109/02652048.2014.911374 · Cited by 46
Hassanzadeh, P., Atyabi, F., Dinarvand, R., Dehpour, A. R., Azhdarzadeh, M., & Dinarvand, M. (2017) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-017-0191-z · Cited by 46
Topical Administration of Terpenes Encapsulated in Nanostructured Lipid-Based Systems
Lasoń, E. (2020) · Molecules · doi:10.3390/molecules25235758 · Cited by 46
Yu, S., Tan, G., Liu, D., Yang, X., & Pan, W. (2017) · RSC Advances · doi:10.1039/c7ra00552k · Cited by 44
Kang, Q., Liu, J., Zhao, Y., Liu, X., Liu, X., Wang, Y., Mo, N.-L., & Wu, Q. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1503599 · Cited by 43
Shahzadi, I., Fürst, A., Knoll, P., & Bernkop‐Schnürch, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081312 · Cited by 43
Shadambikar, G., Marathe, S., Ji, N., Almutairi, M., Bandari, S., Zhang, F., Chougule, M. B., & Repka, M. A. (2021) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2021.100074 · Cited by 41
Nasal drug delivery system - an overview
Alagusundaram, M., Chengaiah, B., Gnanaprakash, K., et al. (2010) · International Journal of Research in Pharmaceutical Sciences · Cited by 38
Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
Silva, S., Bicker, J., Fonseca, C., Ferreira, N. R., Vitorino, C., Alves, G., Falcão, A. C., & Fortuna, A. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.751321 · Cited by 37
Wang, Y., Wang, S., & Shi, P. (2016) · Drug Delivery · doi:10.3109/10717544.2016.1160459 · Cited by 34
A REVIEW ON NASAL DRUG DELIVERY SYSTEM AND ITS CONTRIBUTION IN THERAPEUTIC MANAGEMENT
Alnasser, S. M. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v12i1.29443 · Cited by 30
Mendes, M., Basso, J., Silva, J., Cova, T. F. G. G., Sousa, J., Pais, A. A. C. C., & Vitorino, C. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119661 · Cited by 30
Hsueh, Y., Shyong, Y., Yu, H.-C., Jheng, S.-J., Lin, S.-W., Wu, H., & Tsai, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091386 · Cited by 28
Taymouri, S., Minaiyan, M., Ebrahimi, F., & Tavakoli, N. (2019) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2019.0156 · Cited by 26
Anantaworasakul, P., Anuchapreeda, S., Yotsawimonwat, S., Naksuriya, O., Lekawanvijit, S., Tovanabutra, N., Anantaworasakul, P., Wattanasri, W., Buranapreecha, N., & Ampasavate, C. (2020) · Molecules · doi:10.3390/molecules25235575 · Cited by 21
Nimtrakul, P., Sermsappasuk, P., & Tiyaboonchai, W. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1785050 · Cited by 20
Lages, E. B., Fernandes, R. S., Andrade, M. M. S., Paiyabhroma, N., de Oliveira, R. B., Fernandes, C., Cassali, G. D., Sicard, P., Richard, S., de Barros, A. L. B., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112373 · Cited by 18
Metadata
- Authors
- Khan, S., Sharma, A., & Jain, V.
- Venue
- Advanced Pharmaceutical Bulletin
- Publisher
- Maad Rayan Publishing Company
- Published
- 2022-09-18
- Volume
- 13
- Issue
- 3
- Pages
- 446-460
- ISSN
- 2228-5881 (ISSN-L)
- 2251-7308
- OpenAlex
- W4308069723
- Cited by
- 259
- References
- 90
- FWCI
- 12.27
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.